Periodontal Bone Loss
Conditions
Keywords
Hyaluronic Acid, Suprabony Defect, Surgical Periodontal Therapy, Periodontal Bone Loss
Brief summary
The aim of the present investigation will be evaluated the healing of suprabony defects following surgical flap elevation and hyaluronic acid application respect to surgical flap elevation alone. A total of 80 patients will be enrolled, selected by inclusion and exclusion criteria and randomly divided in two groups: hyaluronic acid group and no-hyaluronic acid group.
Detailed description
The objective of the study will be compare the healing of suprabony defects following treatment with either open flap debridement (OFD) and application of hyaluronic acid (HA) with OFD alone. Eighty patients with suprabony periodontal defects will be randomly assigned to treatment with open flap debridement and application of hyaluronic acid (HA Group) or open flap debridement alone (No-HA Group). Primary outcome will be Clinical Attachment Level (CAL) gain, while the secondary outcomes will be Probing Depth (PD) and Gingival Recession (GR). After local anesthesia, an access flap will be prepared. Depending on the mesiodistal width of the interproximal space, two different incision techniques will be selected to access the suprabony defect area. The modified papilla preservation technique (MMPT) will be used at sites with an interproximal width \> 2 mm, whereas the simplified papilla preservation technique (SPPT) will be applied at sites with an interproximal width ≤ 2 mm. Then, a mucoperiosteal flap will be reflected. Scaling and root planning will be performed combining the use of metal curettes and power-driven instrumentation by means of ultrasonic scaler. Hyaluronic acid will be applied to exposed roots surface only in HA Group followed, for both groups, by a tension-free primary closure of the interdental papillae and of the mucoperiostal flaps by means of 5-0 monofilament (polypropylene) non-resorbable suturing material.
Interventions
PROCEDUREHyaluronic acid
After local anesthesia, an access flap will be prepared. Scaling and root planning will be performed combining the use of metal curettes and power-driven instrumentation by means of ultrasonic scaler. Hyaluronic acid gel will be applied to exposed roots surface, followed by a tension-free primary closure of the surgery wound by means of 5-0 monofilament (polypropylene) non-resorbable suturing material.
PROCEDURENo-hyaluronic acid
An access flap will be prepared in order to perform scaling and root planning therapy with the use of metal curettes. After intervention, a tension-free primary closure of the interdental papillae and of the mucoperiosteal flaps by means of 5-0 monofilament (polypropylene) non-resorbable suturing materia will be performed
Sponsors
Federico II University
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Subject)
Masking description
Only patients will be unaware of the type of treatment performed, with prior written informed consent. So, they will be divided in the two groups of study after a process of randomization
Intervention model description
The study will be designed as a double-arm randomized controlled clinical trial. The suprabony defects of subjects allocated in HA group will be treated with open flap debridement and application of hyaluronic acid, while the suprabony defects of No-HA Group will be treated with open flap debridement alone. The null hypothesis of no statistically significant differences between the two modalities for the treatment of suprabony defects will be tested.
Eligibility
Sex/Gender
ALL
Age
18 Years to 70 Years
Healthy volunteers
Yes
Inclusion criteria
* Patients diagnosed with periodontitis * Age ≥ 18 years old * Single-rooted and multi-rooted teeth * Presence of suprabony periodontal defects at a minimum of two adjacent teeth and a maximum of 7 adjacent teeth in either the maxilla or the mandible with a PD ≥ 5 mm after completion of non-surgical periodontal treatment and re-evaluation * Intrabony defect with an intraosseous component \< 2 mm
Exclusion criteria
* Patients with systemic diseases * Prolonged antibiotic or anti-inflammatory treatment within 4 weeks prior to surgery * Pregnant or lactating * Tobacco smokers (≥ 10 cigarettes per day) * Multi-rooted teeth with furcation involvement * Increased tooth mobility (grade II and III)
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Change of Clinical Attachment Level (CAL) gain (millimeters) | baseline, 6 months after surgical periodontal therapy | Distance from the cementoenamel junction to the bottom of the pocket |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Change of Probing Depth (PD) (millimeters) | baseline, 6 months after surgical periodontal therapy | Distance from the gingival margin to the bottom of the pocket |
| Change of Gingival Recession (GR) (millimeters) | baseline, 6 months after surgical periodontal therapy | Distance from gingival margin to the cementoenamel junction |
Countries
Italy
Outcome results
None listed